HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

1H-MRS assessment of the therapeutic effect of bilateral intraventricular BDNF infusion into APP/PS1 double transgenic mice.

Abstract
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by extracellular accumulation of amyloid deposits. Brain-derived neurotrophic factor (BDNF) is a neurotrophic factor whose levels have been shown to be decreased in AD brains. BDNF supplementation can offer improvement in the course of AD. However, the means of assessment are still relatively limited. In the present study, 1H-MRS was used to evaluate the therapeutic effects of bilateral intraventricular BDNF infusion into Alzheimer's disease APP/PS1 double transgenic mice. For comparison to the 1H-MRS observations, Fluoro-Jade B staining and immunofluorescence for beta amyloid peptides (Aβ), glial fibrillary acidic protein, and tropomyosin-related kinase B (TrkB) were also performed. Our results showed that N-acetylaspartate (NAA) levels increased and myoinositol levels decreased in the BDNF group compared with the PBS group. However, the BDNF group NAA level was still lower than the control group at 6 weeks after infusion. These changes correlated with increased immunoreactivity for TrkB, decreased compact Aβ peptide containing plaques, and decreased Fluoro-Jade B-positive cells in the BDNF-infused mice compared to vehicle controls. These findings demonstrate that 1H-MRS may be a promising means of evaluating the therapeutic effects of BDNF on AD.
AuthorsWei Zhang, Pei-jun Wang, Ming-hua Li, Guo-liang Wang, Ping Li, Xiao-long Gao
JournalJournal of molecular neuroscience : MN (J Mol Neurosci) Vol. 50 Issue 3 Pg. 434-42 (Jul 2013) ISSN: 1559-1166 [Electronic] United States
PMID23315172 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amyloid beta-Peptides
  • Amyloid beta-Protein Precursor
  • Brain-Derived Neurotrophic Factor
  • Glial Fibrillary Acidic Protein
  • Presenilin-1
  • presenilin 1, mouse
  • Aspartic Acid
  • Inositol
  • N-acetylaspartate
  • Receptor, trkB
Topics
  • Alzheimer Disease (drug therapy, genetics)
  • Amyloid beta-Peptides (genetics, metabolism)
  • Amyloid beta-Protein Precursor (genetics)
  • Animals
  • Aspartic Acid (analogs & derivatives, metabolism)
  • Brain-Derived Neurotrophic Factor (administration & dosage, therapeutic use)
  • Glial Fibrillary Acidic Protein (genetics, metabolism)
  • Infusions, Intraventricular
  • Inositol (metabolism)
  • Magnetic Resonance Spectroscopy
  • Mice
  • Mice, Transgenic
  • Presenilin-1 (genetics)
  • Receptor, trkB (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: